AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36289464 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 219
Study 33493211 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole, Mebendazole, and Praziquantel
Number of subjects: 88
Study 33251823 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT self-help book plus phone coaching (GSH-P; n=17)
Number of subjects: 55
Study 33251823 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT self-help book plus email prompts only (GSH-E; n=20)
Number of subjects: 55
Study 33251823 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition (n=18)
Number of subjects: 55
Study 33251823 — intervention group
Group type: EXPERIMENTAL
Intervention: GSH-P
Number of subjects: 55
Study 33251823 — intervention group
Group type: EXPERIMENTAL
Intervention: GSH-E
Number of subjects: 55
Study 34047916 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of metformin (500 mg), pioglitazone (15 mg), and acetyl-L-carnitine (1500 mg), twice daily for 12 weeks
Number of subjects: 147
Study 34047916 — intervention group
Group type: COMPARATOR
Intervention: Metformin (500 mg) plus pioglitazone (15 mg) and placebo (citric acid plus calcium carbonate), twice daily for 12 weeks
Number of subjects: 147
Study 36088373 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisis-focused Cognitive Behavioural Therapy for psychosis (CBTp)
Number of subjects: 60
Study 36088373 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 60
Study 33387179 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive organizational climate with greater readiness for change
Number of subjects: 0
Study 33387179 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34389701 — intervention group
Group type: EXPERIMENTAL
Intervention: D-fortified yogurt drink (DY; containing 1000 IU vitamin D and 300 mg calcium)
Number of subjects: 75
Study 34389701 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca+D-fortified yogurt drink (CDY; containing 1000 IU vitamin D and 500 mg calcium)
Number of subjects: 75
Study 34389701 — intervention group
Group type: COMPARATOR
Intervention: Plain yogurt drink (PY; containing no detectable vitamin D and 300 mg calcium)
Number of subjects: 75
Study 35772625 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial interventions
Number of subjects: 2717
Study 34086190 — intervention group
Group type: EXPERIMENTAL
Intervention: Vericiguat plus standard of care
Number of subjects: 454
Study 34086190 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard of care
Number of subjects: 454
Study 32107818 — intervention group
Group type: EXPERIMENTAL
Intervention: New supraventricular tachycardia (SVT)
Number of subjects: 325
Study 32107818 — intervention group
Group type: EXPERIMENTAL
Intervention: New-onset SVT
Number of subjects: 325
Study 32107818 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate SVT-burden
Number of subjects: 325
Study 32107818 — intervention group
Group type: EXPERIMENTAL
Intervention: High SVT-burden
Number of subjects: 325
Study 36157393 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover backstroke-to-breaststroke turn
Number of subjects: 8
Study 36157393 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae and gastrocnemius medialis
Number of subjects: 8
Study 36157393 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower limb muscles during push-off activity
Number of subjects: 8
Study 36157393 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotation efficacy
Number of subjects: 8
Study 36157393 — intervention group
Group type: EXPERIMENTAL
Intervention: Different turning techniques
Number of subjects: 8
Study 34048641 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone
Number of subjects: 4
Study 34048641 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 33685874 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (patient-centered interdisciplinary multifaceted intervention)
Number of subjects: 284
Study 33685874 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 284
Study 33685874 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 284
Study 33222937 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic disorder patients with skin disease
Number of subjects: 246
Study 33222937 — intervention group
Group type: COMPARATOR
Intervention: Panic disorder patients without skin disease (control group)
Number of subjects: 246
Study 36342851 — intervention group
Group type: EXPERIMENTAL
Intervention: Soothing images
Number of subjects: 149
Study 36342851 — intervention group
Group type: EXPERIMENTAL
Intervention: Soothing sounds
Number of subjects: 149
Study 36342851 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined images and sounds
Number of subjects: 149
Study 36342851 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 149
Study 33590772 — intervention group
Group type: EXPERIMENTAL
Intervention: ramucirumab-paclitaxel
Number of subjects: 317
Study 33590772 — intervention group
Group type: EXPERIMENTAL
Intervention: ramucirumab
Number of subjects: 317
Study 35451061 — intervention group
Group type: EXPERIMENTAL
Intervention: CelA2-M3 (H288F/H524Q) variant
Number of subjects: 36000000
Study 35451061 — intervention group
Group type: COMPARATOR
Intervention: Parent CelA2-H288F
Number of subjects: 36000000
Study 35451061 — intervention group
Group type: COMPARATOR
Intervention: Wildtype CelA2
Number of subjects: 36000000
Study 34086518 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (EN1, N=10)
Number of subjects: 35
Study 34086518 — intervention group
Group type: COMPARATOR
Intervention: Concurrent training (CON, N=13)
Number of subjects: 35
Study 34086518 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (EN2, N=12)
Number of subjects: 35
Study 34086518 — intervention group
Group type: COMPARATOR
Intervention: Endurance training (EN1) vs Concurrent training (CON)
Number of subjects: 35
Study 34086518 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (EN2)
Number of subjects: 35
Study 616082448 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcorneal Electrical Stimulation (TES)
Number of subjects: 12
Study 33219876 — intervention group
Group type: EXPERIMENTAL
Intervention: R25B instruments
Number of subjects: 40
Study 33219876 — intervention group
Group type: EXPERIMENTAL
Intervention: R25 and R25B used in UltraAC
Number of subjects: 40
Study 33219876 — intervention group
Group type: COMPARATOR
Intervention: R25 and R25B without simulated clinical use
Number of subjects: 40
Study 35796290 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactuca Sativa syrup (3 times a day for 72 hours)
Number of subjects: 26
Study 35796290 — intervention group
Group type: COMPARATOR
Intervention: Placebo syrup (3 times a day for 72 hours)
Number of subjects: 26
Study 35796290 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactuca Sativa syrup
Number of subjects: 26
Study 35796290 — intervention group
Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 26
Study 33399939 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-use flexible ureteroscopy
Number of subjects: 0
Study 33399939 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal shock wave lithotripsy
Number of subjects: 0
Study 34910367 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% VC-IP cream
Number of subjects: 69
Study 34910367 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% VC-IP cream
Number of subjects: 69
Study 34910367 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% VC-IP cream
Number of subjects: 69
Study 34910367 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 69
Study 33413038 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyadic reading of books on emotion comprehension for five sessions
Number of subjects: 0
Study 33413038 — intervention group
Group type: COMPARATOR
Intervention: Control group reading classroom books
Number of subjects: 0
Study 33413038 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyadic reading of books on emotion comprehension
Number of subjects: 0
Study 32884020 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 145 mg per day
Number of subjects: 140
Study 32884020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 32884020 — intervention group
Group type: EXPERIMENTAL
Intervention: Both AAA and PAD
Number of subjects: 140
Study 35987634 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical cystectomy
Number of subjects: 109
Study 35987634 — intervention group
Group type: COMPARATOR
Intervention: Bladder sparing operation
Number of subjects: 109
Study 34701458 — intervention group
Group type: EXPERIMENTAL
Intervention: GC4711 100 mg IV infusion prior to each SBRT (5×10Gy)
Number of subjects: 160
Study 34701458 — intervention group
Group type: COMPARATOR
Intervention: Placebo IV infusion prior to each SBRT (5×10Gy)
Number of subjects: 160
Study 35857305 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic gastrectomy
Number of subjects: 1050
Study 35857305 — intervention group
Group type: COMPARATOR
Intervention: Open gastrectomy
Number of subjects: 1050
Study 34528277 — intervention group
Group type: EXPERIMENTAL
Intervention: IV administration of dexmedetomidine (loading dose 1.75 mcg/kg bwt followed by 1.75 mcg/kg bwt/h) with concurrent target sevoflurane dose reduction of 50%.
Number of subjects: 13
Study 34528277 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (group LPS; seven horses).
Number of subjects: 13
Study 32924561 — intervention group
Group type: EXPERIMENTAL
Intervention: Homemade salivary substitute prepared using chamomile flower and flax seed
Number of subjects: 40
Study 32924561 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamomile flower and flax seed
Number of subjects: 40
Study 33318079 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum based chemotherapy plus atezolizumab followed by maintenance niraparib plus atezolizumab
Number of subjects: 414
Study 33318079 — intervention group
Group type: COMPARATOR
Intervention: Platinum based chemotherapy plus placebo of atezolizumab followed by maintenance niraparib plus placebo of atezolizumab
Number of subjects: 414
Study 32507421 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantago major syrup
Number of subjects: 46
Study 32507421 — intervention group
Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 46
Study 33993394 — intervention group
Group type: EXPERIMENTAL
Intervention: Home management with auto-titrating CPAP (APAP) therapy and telemonitoring
Number of subjects: 224
Study 33993394 — intervention group
Group type: COMPARATOR
Intervention: Standard care with diagnostic polysomnography (PSG) and in-lab APAP initiation
Number of subjects: 224
Study 32960272 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz/emtricitabine/tenofovir disoproxil fumarate (TDF)
Number of subjects: 510
Study 32960272 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir/emtricitabine/TDF
Number of subjects: 510
Study 32960272 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (Efavirenz and Dolutegravir)
Number of subjects: 510
Study 32171278 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive outreach treatment (AOT) plus care as usual (CAU)
Number of subjects: 160
Study 32171278 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 160
Study 36261145 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP treatment with nasal mask or prongs
Number of subjects: 50
Study 36261145 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP treatment
Number of subjects: 50
Study 32854150 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g/kg/d S‐ILE for 6 weeks
Number of subjects: 40
Study 32854150 — intervention group
Group type: COMPARATOR
Intervention: 2 g/kg/d S‐ILE for 6 weeks
Number of subjects: 40
Study 33253259 — intervention group
Group type: EXPERIMENTAL
Intervention: tDNA-MI (structured low-calorie meal plan, diabetes-specific meal replacements, exercise prescription, and motivational interviewing)
Number of subjects: 230
Study 33253259 — intervention group
Group type: EXPERIMENTAL
Intervention: tDNA-CC (structured low-calorie meal plan, diabetes-specific meal replacements, exercise prescription, and conventional counseling)
Number of subjects: 230
Study 33253259 — intervention group
Group type: COMPARATOR
Intervention: UC (usual care with standard dietary and exercise advice using conventional counseling)
Number of subjects: 230
Study 33253259 — intervention group
Group type: EXPERIMENTAL
Intervention: tDNA-MI
Number of subjects: 230
Study 33253259 — intervention group
Group type: EXPERIMENTAL
Intervention: tDNA-CC
Number of subjects: 230
Study 33253259 — intervention group
Group type: COMPARATOR
Intervention: UC
Number of subjects: 230
Study 33541218 — intervention group
Group type: EXPERIMENTAL
Intervention: IO access using Arrow EZ-IO Vascular Access System in the proximal humerus or proximal tibia for 48 h
Number of subjects: 121
Study 32428959 — intervention group
Group type: EXPERIMENTAL
Intervention: Aftercare by a specialist trained in osteology
Number of subjects: 70
Study 32428959 — intervention group
Group type: COMPARATOR
Intervention: Regular aftercare by general practitioners or orthopedic surgeons
Number of subjects: 70
Study 35030530 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (35% fat, 22% MUFA, <50% carbohydrates)
Number of subjects: 1002
Study 35030530 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (28% fat, 12% MUFA, >55% carbohydrates)
Number of subjects: 1002
Study 35030530 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 1002
Study 35030530 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 1002
Study 35030530 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 1002
Study 34618594 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary payments of 24 US dollars (200 Swedish kronor)
Number of subjects: 8286
Study 34618594 — intervention group
Group type: COMPARATOR
Intervention: Behavioral nudges
Number of subjects: 8286
Study 33208665 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrofiber dressing
Number of subjects: 17
Study 33208665 — intervention group
Group type: COMPARATOR
Intervention: Polyurethane foam dressing
Number of subjects: 17
Study 33208665 — intervention group
Group type: COMPARATOR
Intervention: Porcine xenograft dressing
Number of subjects: 17
Study 34364702 — intervention group
Group type: EXPERIMENTAL
Intervention: Battlefield acupuncture (BFA)
Number of subjects: 52
Study 34364702 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacologic therapies (Control)
Number of subjects: 52
Study 33037261 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training (CT) - resistance training and aerobic training, 60 min, three times a week for 12 weeks
Number of subjects: 37
Study 33037261 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - no intervention
Number of subjects: 37
Study 33037261 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training (CT)
Number of subjects: 37
Study 36111518 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural group therapy for insomnia (CBGT-I)
Number of subjects: 116
Study 36111518 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 116
Study 33785660 — intervention group
Group type: EXPERIMENTAL
Intervention: YogaMT (yoga exercises and medial thrust gait)
Number of subjects: 59
Study 33785660 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee-strengthening group (quadriceps and hamstring strengthening exercises)
Number of subjects: 59
Study 33785660 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking group (normal treadmill walking)
Number of subjects: 59
Study 32132827 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching for 3 minutes (3 × 60 s)
Number of subjects: 14
Study 33084818 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy
Number of subjects: 20
Study 33084818 — intervention group
Group type: COMPARATOR
Intervention: Oral steroid and cyclosporine‐A (immune modulator therapy)
Number of subjects: 20
Study 33835084 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDFT) guided by left ventricular outflow tract velocity time integral (LVOT-VTI)
Number of subjects: 50
Study 33835084 — intervention group
Group type: COMPARATOR
Intervention: Central venous pressure (CVP)-guided fluid management
Number of subjects: 50
Study 33835084 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative variables (including creatinine, duration of postoperative mechanical ventilation, length of intensive care unit and hospital stay, incidence of acute kidney injury, pneumonitis, and vasospasm)
Number of subjects: 50
Study 34849424 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized clinical trial (RCT)
Number of subjects: 40
Study 34849424 — intervention group
Group type: EXPERIMENTAL
Intervention: VAS anxiety score of 5 or more
Number of subjects: 40
Study 34849424 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 40
Study 34849424 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life (QoL) – Personal development subdomain
Number of subjects: 40
Study 35617742 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 0
Study 35617742 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32744392 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-glucose cotransporter-2 inhibitors (SGLT2i)
Number of subjects: 0
Study 32744392 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 35840445 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga Group (add-on yoga therapy and continuing prescribed medication)
Number of subjects: 60
Study 35840445 — intervention group
Group type: COMPARATOR
Intervention: Control Group (continuing prescribed medication only)
Number of subjects: 60
Study 33237442 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective repair
Number of subjects: 34
Study 33237442 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 34
Study 33237442 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life (PCS and MCS)
Number of subjects: 34
Study 35392908 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib 150 mg twice daily
Number of subjects: 663
Study 35392908 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 663
Study 32051972 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine (CHX)
Number of subjects: 33
Study 32051972 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronan (HA)
Number of subjects: 33
Study 32051972 — intervention group
Group type: COMPARATOR
Intervention: Distilled Water (DW)
Number of subjects: 33
Study 35963795 — intervention group
Group type: EXPERIMENTAL
Intervention: EVM+waveform
Number of subjects: 10
Study 35963795 — intervention group
Group type: COMPARATOR
Intervention: EVM processed
Number of subjects: 10
Study 35963795 — intervention group
Group type: COMPARATOR
Intervention: Unprocessed
Number of subjects: 10
Study 33482850 — intervention group
Group type: EXPERIMENTAL
Intervention: LIA in the deep and superficial fascia (group A)
Number of subjects: 120
Study 33482850 — intervention group
Group type: EXPERIMENTAL
Intervention: LIA in all layers (group B)
Number of subjects: 120
Study 33482850 — intervention group
Group type: COMPARATOR
Intervention: Control (group C)
Number of subjects: 120
Study 33349641 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical mask (SM)
Number of subjects: 14
Study 35377931 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% tetracaine plus 0.05% oxymetazoline nasal spray (Kovanaze; KNS)
Number of subjects: 20
Study 35377931 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine (LE)
Number of subjects: 20
Study 35377931 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% mepivacaine plain (MP)
Number of subjects: 20
Study 35377931 — intervention group
Group type: COMPARATOR
Intervention: mock nasal spray (placebo)
Number of subjects: 20
Study 34757343 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg (2 hours preoperative)
Number of subjects: 62
Study 33261618 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable device with real-time feedback (n=29)
Number of subjects: 59
Study 33261618 — intervention group
Group type: COMPARATOR
Intervention: PA measured but not visible (n=30)
Number of subjects: 59
Study 33261618 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (n=59)
Number of subjects: 59
Study 33781212 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulated Oral Airway (AOA)
Number of subjects: 58
Study 33781212 — intervention group
Group type: COMPARATOR
Intervention: Guedel Oral Airway (GOA)
Number of subjects: 58
Study 32140889 — intervention group
Group type: EXPERIMENTAL
Intervention: Galunisertib plus TMZ/RTX (n = 40)
Number of subjects: 56
Study 32140889 — intervention group
Group type: COMPARATOR
Intervention: TMZ/RTX (control arm, n = 16)
Number of subjects: 56
Study 34728252 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral optical scanning (IOS)
Number of subjects: 40
Study 34728252 — intervention group
Group type: COMPARATOR
Intervention: Conventional impressions
Number of subjects: 40
Study 34728252 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium disilicate (LS2)
Number of subjects: 40
Study 34728252 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer-infiltrated ceramic networks (PICN)
Number of subjects: 40
Study 34728252 — intervention group
Group type: EXPERIMENTAL
Intervention: Final implant restorations assessed by FIPS
Number of subjects: 40
Study 34013356 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio tape
Number of subjects: 34
Study 34013356 — intervention group
Group type: COMPARATOR
Intervention: Micropore tape
Number of subjects: 34
Study 34010312 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice call reminder intervention
Number of subjects: 690
Study 34010312 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health volunteer (CHV) intervention with incentivized rewards
Number of subjects: 690
Study 34010312 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 690
Study 32952230 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective upper and lower alveolar decortication and 3D collagen matrix
Number of subjects: 40